Telemedicine is defined as the practice of medicine using electronic communication and information technology. Telemonitoring (TM) consists on wireless transmission of physiological data.

Obstructive sleep apnoea (OSA) is a chronic disorder associated with a significant morbidity and mortality. Continous positive airway pressure (CPAP) is the mainstay of treatment improving quality of life and reducing mortality. Correct compliance to CPAP remains the greatest challenge, and the adoption of TM enhances disease management.

We did a descriptive study of  patients with telemonitored (TM-CPAP) treatment. Assessment of efficacy of such a control

In accordance with Clinical Guidelines of OSA treatment we enrolled patients in asynchronous TM-CPAP. Their CPAP devices  (Ibreeze 20C ResVent®) have wireless built-in connectivity and transfer technical data via secured data central (cloud). During the first month the most important features were collected: adherence, mask leaks and residual apnoeas. In case of patients with problems new reassuring interventions were performed.

We enrolled 54 patients on TM-CPAP. 45 males and  9 women, all of them with severe OSA. Data in table. Remoted data were collected one month after CPAP beginning. 32 (59.25%) patients were correctly adapted. In case of problems a new encouraging  intervention and a 2 month later control were accomplished.  At this time 38 (70,38%) patients were  good compliant. In this case we switch TM-CPAP to usual CPAP. Patients with no adherence at all are followed-up for the nexts months and go on with TM-CPAP.

Our conclussions most important were that TM-CPAP follow-up provides an early control after the beginning of treatment and triggers an intensive intervention in case of compliance problems.